Bluejay Diagnostics
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Employees
- 10
- Market Cap
- -
- Introduction
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
- Conditions
- Sepsis, Septic Shock
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 700
- Registration Number
- NCT06654895
- Locations
- ๐บ๐ธ
University of Florida College of Medicine, Gainesville, Florida, United States
๐บ๐ธBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
๐บ๐ธWake Forest School of Medicine, Winston Salem, North Carolina, United States
Multicenter Symphony IL-6 Monitoring Sepsis ICU Study
- Conditions
- SepsisSeptic Shock
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT06181604
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
๐บ๐ธNewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
๐บ๐ธWashington University of St. Louis, Saint Louis, Missouri, United States
Symphony IL-6 Study in Patients at Risk of Severe Sepsis
- Conditions
- Severe Sepsis
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05665153
- Locations
- ๐บ๐ธ
University of Michigan Medical Center, Ann Arbor, Michigan, United States
Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19
- Conditions
- Severe Sepsis
- First Posted Date
- 2021-09-29
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT05060250
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Acton, Texas, United States
Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis
- Conditions
- Severe Sepsis
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT05048927
- Locations
- ๐บ๐ธ
Tina McCarthy, Acton, Texas, United States
Symphony IL-6 Reference Range Study
- Conditions
- Sepsis
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Bluejay Diagnostics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05048888
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States